New more sensitive diagnostics protect transplanted kidney
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
News | July 3, 2018
Devyser is pleased to announce the publication of a new whitepaper Familial Hypercholesterolemia: Genetic Diagnosis and Cascade Testing Using NGS
The 6th in our Expert Review series, this paper is co-authored by Peter Benedek and Kristina Duvefelt, of Karolinska University Hospital, Stockholm.
The paper is a guide to conducting testing using NGS, and the benefits of implementing cascade screening for FH, which is a dominant yet highly underdiagnosed heriditary disorder. Affected individuals are affected by high levels of LDL-cholesterol, and early onset cardiovascular disease and death.
With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...
Read More
Devyser, the pioneering leader in diagnostic solutions, launches today its first IVDR-certified...
Read More
“Further strong organic growth was reported for the year and quarter. Efforts to build an...
Read More
We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for...
Read More